Academician
AZİZE GİZEM ERGÜL
Doktor Öğretim Üyesi
Gazi Üniversitesi Eczacılık Fakültesi Eczacılık Meslek Bilimleri Bölümü
Research topics OpenAlex
- Inflammatory mediators and NSAID effects3
- Estrogen and related hormone effects2
- Synthesis and biological activity2
- Eicosanoids and Hypertension Pharmacology1
- Enzyme function and inhibition1
- Nanoparticle-Based Drug Delivery1
- Advanced Drug Delivery Systems1
- Neuropeptides and Animal Physiology1
- Synthesis and Catalytic Reactions1
- Cytokine Signaling Pathways and Interactions1
- NF-κB Signaling Pathways1
- Chemical Reactions and Mechanisms1
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmasotik Kimya
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 6
h-index
4
Percentile in Türkiye: 53
#1,321 of 2,185 at their university by h-index
- i10-index
- 2
- Total citations
- 63 Top 44% in Türkiye
- Per article
- 10.5
- FWCI
- 1.46 1.00 = world average
- World top 1%
- 0
- World top 10%
- 1
Most cited articles
- Benzimidazole derivatives as potent and isoform selective tumor-associated carbonic anhydrase IX/XII inhibitors
- Novel potent benzimidazole-based microsomal prostaglandin E-2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C-4 synthase
- Novel Benzimidazole Derivatives as Potent Inhibitors of Microsomal Prostaglandin E2 Synthase 1 for the Potential Treatment of Inflammation, Pain, and Fever
How is this computed?
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.
Field ranking
YÖKSİS ?-
Main field Sağlık Bilimleri Temel AlanıPoints rank #24,417/ 39,749 top 61.4% At university #681/ 856Score 6.25 journal 6 · OA add 0.25
- Article rank27,700/39,749
- Scopus rank24,471/39,749
- WoS rank24,253/39,749
- YÖKSİS6
- Scopus6
- WoS6
-
Side field Farmasotik KimyaPoints rank #122/ 206 top 59.2% At university #15/ 19Score 6.25 journal 6 · OA add 0.25
- Article rank137/206
- Scopus rank130/206
- WoS rank123/206
- YÖKSİS6
- Scopus6
- WoS6
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 18
- With an akaturk profile
- 6
- Turkish institutions
- 0
- Co-authored works
- %100
Academic co-authors 6
- BURCU ÇALIŞKAN Profesör · Gazi Üniversitesi same university 6
- ERDEN BANOĞLU Profesör · Gazi Üniversitesi same university 6
- ABDURRAHMAN OLĞAÇ Doktor Öğretim Üyesi · Gazi Üniversitesi same university 4
- ZEHRA TUĞÇE GÜR MAZ Doçent · Gazi Üniversitesi same university 3
- MECİT ORHAN ULUDAĞ Profesör · Gazi Üniversitesi same university 1
- NUR BANU BAL Doçent · Gazi Üniversitesi same university 1
National collaboration 0 institutions
Within own university6 joint works · Gazi Üniversitesi
No joint work with another Turkish university.
Other co-authors (incl. international) 12
Oliver Werz 5Paul M. Jordan 5Philipp Dahlke 3Alessio NocentiniAntje VollrathChristian KretzerClaudiu T. SupuranLea C. KlepschSchubert Ulrich SSteffi StumpfStephanie HoeppenerSÜMEYYE TURANLI
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.
Indexes and citation percentiles
?Top 1%0
Top 10%1
Avg · n 6
%77.0
Other counts
Scopus (SJR)
- YÖKSİS rows 6
WoS (JCR)
- YÖKSİS rows 6
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
5 journals
Narrow down
Article list
- 2025 Enhanced Efficiency of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AGU661 in Human Whole Blood by Encapsulation into PLGA-Based Nanoparticles YÖKSİS SJR Q1 JCR Q1 OpenAlex 72.2%
- 2024 Novel Benzimidazole Derivatives as Potent Inhibitors of Microsomal Prostaglandin E2 Synthase 1 for the Potential Treatment of Inflammation, Pain, and Fever YÖKSİS SJR Q1 JCR Q1 OpenAlex 88.8%
- 2024 Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors YÖKSİS SJR Q1 JCR Q1 OpenAlex 67.7%
- 2022 Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition YÖKSİS SJR Q1 JCR Q2 OpenAlex 67.0%
- 2022 Novel potent benzimidazole-based microsomal prostaglandin E-2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C-4 synthase YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 90.9%
- 2020 Benzimidazole derivatives as potent and isoform selective tumor-associated carbonic anhydrase IX/XII inhibitors YÖKSİS SJR Q2 JCR Q1 OpenAlex 75.1%